BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21300949)

  • 1. Preservation of the capacity to appoint a proxy decision maker: implications for dementia research.
    Kim SY; Karlawish JH; Kim HM; Wall IF; Bozoki AC; Appelbaum PS
    Arch Gen Psychiatry; 2011 Feb; 68(2):214-20. PubMed ID: 21300949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological correlates of capacity determinations in Alzheimer disease: implications for assessment.
    Palmer BW; Ryan KA; Kim HM; Karlawish JH; Appelbaum PS; Kim SY
    Am J Geriatr Psychiatry; 2013 Apr; 21(4):373-81. PubMed ID: 23498384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The capacity to appoint a proxy and the possibility of concurrent proxy directives.
    Kim SY; Appelbaum PS
    Behav Sci Law; 2006; 24(4):469-78. PubMed ID: 16883617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability of judgments of capacity: experience of capacity evaluators in a study of research consent capacity.
    Kim SY; Appelbaum PS; Kim HM; Wall IF; Bourgeois JA; Frankel B; Hails KC; Rundell JR; Seibel KM; Karlawish JH
    Psychosomatics; 2011; 52(4):346-53. PubMed ID: 21777717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Capacity to Consent to Research on Alzheimer's disease.
    Palmer BW; Harmell AL; Pinto LL; Dunn LB; Kim SY; Golshan S; Jeste DV
    Clin Gerontol; 2017; 40(1):24-34. PubMed ID: 28154452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the capacity to appoint a healthcare proxy.
    Moye J; Sabatino CP; Weintraub Brendel R
    Am J Geriatr Psychiatry; 2013 Apr; 21(4):326-36. PubMed ID: 23498379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomy, authenticity, or best interest: everyday decision-making and persons with dementia.
    Holm S
    Med Health Care Philos; 2001; 4(2):153-9. PubMed ID: 11547501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Older adults' attitudes toward enrollment of non-competent subjects participating in Alzheimer's research.
    Karlawish J; Rubright J; Casarett D; Cary M; Ten Have T; Sankar P
    Am J Psychiatry; 2009 Feb; 166(2):182-8. PubMed ID: 18923066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research.
    Kim SY; Caine ED; Currier GW; Leibovici A; Ryan JM
    Am J Psychiatry; 2001 May; 158(5):712-7. PubMed ID: 11329391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research involving adults lacking capacity to consent: a content analysis of participant information sheets for consultees and legal representatives in England and Wales.
    Shepherd V; Wood F; Griffith R; Sheehan M; Hood K
    Trials; 2019 Apr; 20(1):233. PubMed ID: 31023383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An under-represented and underserved population in trials: methodological, structural, and systemic barriers to the inclusion of adults lacking capacity to consent.
    Shepherd V
    Trials; 2020 May; 21(1):445. PubMed ID: 32471488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "A feeling that you're helping": proxy decision making for Alzheimer's research.
    Dunn LB; Hoop JG; Misra S; Fisher SR; Roberts LW
    Narrat Inq Bioeth; 2011; 1(2):107-22. PubMed ID: 24406656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A memory and organizational aid improves Alzheimer disease research consent capacity: results of a randomized, controlled trial.
    Rubright J; Sankar P; Casarett DJ; Gur R; Xie SX; Karlawish J
    Am J Geriatr Psychiatry; 2010 Dec; 18(12):1124-32. PubMed ID: 20808101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpreting the clinical significance of capacity scores for informed consent in Alzheimer disease clinical trials.
    Karlawish J; Kim SY; Knopman D; van Dyck CH; James BD; Marson D
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):568-74. PubMed ID: 18556397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research with Alzheimer's disease subjects: informed consent and proxy decision making.
    High DM
    J Am Geriatr Soc; 1992 Sep; 40(9):950-7. PubMed ID: 1512393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment.
    Karlawish JH; Casarett DJ; James BD; Xie SX; Kim SY
    Neurology; 2005 May; 64(9):1514-9. PubMed ID: 15883310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consistency of physicians' legal standard and personal judgments of competency in patients with Alzheimer's disease.
    Marson DC; Earnst KS; Jamil F; Bartolucci A; Harrell LE
    J Am Geriatr Soc; 2000 Aug; 48(8):911-8. PubMed ID: 10968294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment.
    Karlawish J; Kim SY; Knopman D; van Dyck CH; James BD; Marson D
    Am J Geriatr Psychiatry; 2008 Mar; 16(3):240-7. PubMed ID: 18310554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogate consent for dementia research: a national survey of older Americans.
    Kim SY; Kim HM; Langa KM; Karlawish JH; Knopman DS; Appelbaum PS
    Neurology; 2009 Jan; 72(2):149-55. PubMed ID: 19139366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What do people at risk for Alzheimer disease think about surrogate consent for research?
    Kim SY; Kim HM; McCallum C; Tariot PN
    Neurology; 2005 Nov; 65(9):1395-401. PubMed ID: 16275826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.